Karo Pharma: Interim report H1 2022
HUDDINGE, Sweden, July 21, 2022 /PRNewswire/ -- January - June Revenues amounted to MSEK 1 965.3 (1 460.9), corresponding to an increase of +35% for the period.
Source: finanznachrichten.de
Stay updated with breaking news from Sylphar Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HUDDINGE, Sweden, July 21, 2022 /PRNewswire/ -- January - June Revenues amounted to MSEK 1 965.3 (1 460.9), corresponding to an increase of +35% for the period.
HUDDINGE, Sweden, Nov. 23, 2021 /PRNewswire/ -- Karo Pharma Aktiebolag (publ) (the "Company" or "Karo") has today entered into an agreement to acquire all of the shares in Sylphar International